* From settlements between the federal and state governments and pharmaceutical manufacturers.
An additional multi-state settlement, reached in 2016 with Teva’s Cephalon subsidiary for monopoly practices, involved a $125 million civil monetary fine. However, the entirety of this fine was paid from a previous (2015) $1.2 billion civil settlement payment by Teva’s Cephalon subsidiary to the federal government. Because this $1.2 billion federal financial penalty already was included in our database, we did not include the $125 million multi-state settlement payment so as not to count Teva’s settlement payment twice.
Citation formats
Pharmaceutical industry financial penalties - United States 1991-2017
This statistic represents pharmaceutical industry penalties from settlements between US state and federal governments from 1991 to 2017. In 2009, penalties for the pharmaceutical industry in the United States came to some 4.4 billion U.S. dollars in total.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Public Citizen. (March 14, 2018). Pharmaceutical industry financial penalties in the United States from 1991 to 2017 (in million U.S. dollars)* [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 29, 2026, from /statistics/278603/pharmaceutical-industry-settlements-with-us-state-and-federal-governments/
Public Citizen. "Pharmaceutical industry financial penalties in the United States from 1991 to 2017 (in million U.S. dollars)*." Chart. March 14, 2018. ÌÇÐÄÆƽâ°æ. Accessed July 29, 2026. /statistics/278603/pharmaceutical-industry-settlements-with-us-state-and-federal-governments/
Public Citizen. (2018). Pharmaceutical industry financial penalties in the United States from 1991 to 2017 (in million U.S. dollars)*. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 29, 2026. /statistics/278603/pharmaceutical-industry-settlements-with-us-state-and-federal-governments/
Public Citizen. "Pharmaceutical Industry Financial Penalties in The United States from 1991 to 2017 (in Million U.S. Dollars)*." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 14 Mar 2018, /statistics/278603/pharmaceutical-industry-settlements-with-us-state-and-federal-governments/
Public Citizen, Pharmaceutical industry financial penalties in the United States from 1991 to 2017 (in million U.S. dollars)* ÌÇÐÄÆƽâ°æ, /statistics/278603/pharmaceutical-industry-settlements-with-us-state-and-federal-governments/ (last visited July 29, 2026)
Pharmaceutical industry financial penalties in the United States from 1991 to 2017 (in million U.S. dollars)* [Graph], Public Citizen, March 14, 2018. [Online]. Available: /statistics/278603/pharmaceutical-industry-settlements-with-us-state-and-federal-governments/
